OBJECTIVE: The authors used a genome-wide association study (GWAS) of multiply affected families to investigate the association of schizophrenia to common single-nucleotide polymorphisms (SNPs) and rare copy number variants (CNVs). METHOD: The family sample included 2,461 individuals from 631 pedigrees (581 in the primary European-ancestry analyses). Association was tested for single SNPs and genetic pathways. Polygenic scores based on family study results were used to predict case-control status in the Schizophrenia Psychiatric GWAS Consortium (PGC) data set, and consistency of direction of effect with the family study was determined for top SNPs in the PGC GWAS analysis. Within-family segregation was examined for schizophrenia-associated rare CNVs. RESULTS: No genome-wide significant associations were observed for single SNPs or for pathways. PGC case and control subjects had significantly different genome-wide polygenic scores (computed by weighting their genotypes by log-odds ratios from the family study) (best p=10(-17), explaining 0.4% of the variance). Family study and PGC analyses had consistent directions for 37 of the 58 independent best PGC SNPs (p=0.024). The overall frequency of CNVs in regions with reported associations with schizophrenia (chromosomes 1q21.1, 15q13.3, 16p11.2, and 22q11.2 and the neurexin-1 gene [NRXN1]) was similar to previous case-control studies. NRXN1 deletions and 16p11.2 duplications (both of which were transmitted from parents) and 22q11.2 deletions (de novo in four cases) did not segregate with schizophrenia in families. CONCLUSIONS: Many common SNPs are likely to contribute to schizophrenia risk, with substantial overlap in genetic risk factors between multiply affected families and cases in large case-control studies. Our findings are consistent with a role for specific CNVs in disease pathogenesis, but the partial segregation of some CNVs with schizophrenia suggests that researchers should exercise caution in using them for predictive genetic testing until their effects in diverse populations have been fully studied.
OBJECTIVE: The authors used a genome-wide association study (GWAS) of multiply affected families to investigate the association of schizophrenia to common single-nucleotide polymorphisms (SNPs) and rare copy number variants (CNVs). METHOD: The family sample included 2,461 individuals from 631 pedigrees (581 in the primary European-ancestry analyses). Association was tested for single SNPs and genetic pathways. Polygenic scores based on family study results were used to predict case-control status in the Schizophrenia Psychiatric GWAS Consortium (PGC) data set, and consistency of direction of effect with the family study was determined for top SNPs in the PGC GWAS analysis. Within-family segregation was examined for schizophrenia-associated rare CNVs. RESULTS: No genome-wide significant associations were observed for single SNPs or for pathways. PGC case and control subjects had significantly different genome-wide polygenic scores (computed by weighting their genotypes by log-odds ratios from the family study) (best p=10(-17), explaining 0.4% of the variance). Family study and PGC analyses had consistent directions for 37 of the 58 independent best PGC SNPs (p=0.024). The overall frequency of CNVs in regions with reported associations with schizophrenia (chromosomes 1q21.1, 15q13.3, 16p11.2, and 22q11.2 and the neurexin-1 gene [NRXN1]) was similar to previous case-control studies. NRXN1 deletions and 16p11.2 duplications (both of which were transmitted from parents) and 22q11.2 deletions (de novo in four cases) did not segregate with schizophrenia in families. CONCLUSIONS: Many common SNPs are likely to contribute to schizophrenia risk, with substantial overlap in genetic risk factors between multiply affected families and cases in large case-control studies. Our findings are consistent with a role for specific CNVs in disease pathogenesis, but the partial segregation of some CNVs with schizophrenia suggests that researchers should exercise caution in using them for predictive genetic testing until their effects in diverse populations have been fully studied.
Authors: Q Cao; M Martinez; J Zhang; A R Sanders; J A Badner; A Cravchik; C J Markey; E Beshah; J J Guroff; M E Maxwell; D M Kazuba; R Whiten; L R Goldin; E S Gershon; P V Gejman Journal: Genomics Date: 1997-07-01 Impact factor: 5.736
Authors: D F Levinson; M M Mahtani; D J Nancarrow; D M Brown; L Kruglyak; A Kirby; N K Hayward; R R Crowe; N C Andreasen; D W Black; J M Silverman; J Endicott; L Sharpe; R C Mohs; L J Siever; M K Walters; D P Lennon; H L Jones; D A Nertney; M J Daly; M Gladis; B J Mowry Journal: Am J Psychiatry Date: 1998-06 Impact factor: 18.112
Authors: K S Kendler; F A O'Neill; J Burke; B Murphy; F Duke; R E Straub; R Shinkwin; M Ni Nuallain; C J MacLean; D Walsh Journal: Am J Med Genet Date: 1996-04-09
Authors: F Bonnet-Brilhault; C Laurent; D Campion; F Thibaut; C Lafargue; F Charbonnier; J F Deleuze; J F Ménard; M Jay; M Petit; T Frebourg; J Mallet Journal: Eur J Hum Genet Date: 1999 Feb-Mar Impact factor: 4.246
Authors: S V Faraone; M Blehar; J Pepple; S O Moldin; J Norton; J I Nurnberger; D Malaspina; C A Kaufmann; T Reich; C R Cloninger; J R DePaulo; K Berg; E S Gershon; D G Kirch; M T Tsuang Journal: Psychol Med Date: 1996-03 Impact factor: 7.723
Authors: P A Holmans; B Riley; A E Pulver; M J Owen; D B Wildenauer; P V Gejman; B J Mowry; C Laurent; K S Kendler; G Nestadt; N M Williams; S G Schwab; A R Sanders; D Nertney; J Mallet; B Wormley; V K Lasseter; M C O'Donovan; J Duan; M Albus; M Alexander; S Godard; R Ribble; K Y Liang; N Norton; W Maier; G Papadimitriou; D Walsh; M Jay; A O'Neill; F B Lerer; D Dikeos; R R Crowe; J M Silverman; D F Levinson Journal: Mol Psychiatry Date: 2009-02-17 Impact factor: 15.992
Authors: Hreinn Stefansson; Roel A Ophoff; Stacy Steinberg; Ole A Andreassen; Sven Cichon; Dan Rujescu; Thomas Werge; Olli P H Pietiläinen; Ole Mors; Preben B Mortensen; Engilbert Sigurdsson; Omar Gustafsson; Mette Nyegaard; Annamari Tuulio-Henriksson; Andres Ingason; Thomas Hansen; Jaana Suvisaari; Jouko Lonnqvist; Tiina Paunio; Anders D Børglum; Annette Hartmann; Anders Fink-Jensen; Merete Nordentoft; David Hougaard; Bent Norgaard-Pedersen; Yvonne Böttcher; Jes Olesen; René Breuer; Hans-Jürgen Möller; Ina Giegling; Henrik B Rasmussen; Sally Timm; Manuel Mattheisen; István Bitter; János M Réthelyi; Brynja B Magnusdottir; Thordur Sigmundsson; Pall Olason; Gisli Masson; Jeffrey R Gulcher; Magnus Haraldsson; Ragnheidur Fossdal; Thorgeir E Thorgeirsson; Unnur Thorsteinsdottir; Mirella Ruggeri; Sarah Tosato; Barbara Franke; Eric Strengman; Lambertus A Kiemeney; Ingrid Melle; Srdjan Djurovic; Lilia Abramova; Vasily Kaleda; Julio Sanjuan; Rosa de Frutos; Elvira Bramon; Evangelos Vassos; Gillian Fraser; Ulrich Ettinger; Marco Picchioni; Nicholas Walker; Timi Toulopoulou; Anna C Need; Dongliang Ge; Joeng Lim Yoon; Kevin V Shianna; Nelson B Freimer; Rita M Cantor; Robin Murray; Augustine Kong; Vera Golimbet; Angel Carracedo; Celso Arango; Javier Costas; Erik G Jönsson; Lars Terenius; Ingrid Agartz; Hannes Petursson; Markus M Nöthen; Marcella Rietschel; Paul M Matthews; Pierandrea Muglia; Leena Peltonen; David St Clair; David B Goldstein; Kari Stefansson; David A Collier Journal: Nature Date: 2009-07-01 Impact factor: 49.962
Authors: Anna R Docherty; Eduardo Fonseca-Pedrero; Martin Debbané; Raymond C K Chan; Richard J Linscott; Katherine G Jonas; David C Cicero; Melissa J Green; Leonard J Simms; Oliver Mason; David Watson; Ulrich Ettinger; Monika Waszczuk; Alexander Rapp; Phillip Grant; Roman Kotov; Colin G DeYoung; Camilo J Ruggero; Nicolas R Eaton; Robert F Krueger; Christopher Patrick; Christopher Hopwood; F Anthony O'Neill; David H Zald; Christopher C Conway; Daniel E Adkins; Irwin D Waldman; Jim van Os; Patrick F Sullivan; John S Anderson; Andrey A Shabalin; Scott R Sponheim; Stephan F Taylor; Rachel G Grazioplene; Silviu A Bacanu; Tim B Bigdeli; Corinna Haenschel; Dolores Malaspina; Diane C Gooding; Kristin Nicodemus; Frauke Schultze-Lutter; Neus Barrantes-Vidal; Christine Mohr; William T Carpenter; Alex S Cohen Journal: Schizophr Bull Date: 2018-10-15 Impact factor: 9.306
Authors: Vural Ozdemir; Laszlo Endrenyi; Sükrü Aynacıoğlu; Nicola Luigi Bragazzi; Collet Dandara; Edward S Dove; Lynnette R Ferguson; Christy Jo Geraci; Ernst Hafen; Belgin Eroğlu Kesim; Eugene Kolker; Edmund J D Lee; Adrian Llerena; Muradiye Nacak; Kazutaka Shimoda; Toshiyuki Someya; Sanjeeva Srivastava; Brian Tomlinson; Effy Vayena; Louise Warnich; Umit Yaşar Journal: OMICS Date: 2014-03-20
Authors: Jubao Duan; Jianxin Shi; Alessia Fiorentino; Catherine Leites; Xiangning Chen; Winton Moy; Jingchun Chen; Boian S Alexandrov; Anny Usheva; Deli He; Jessica Freda; Niamh L O'Brien; Andrew McQuillin; Alan R Sanders; Elliot S Gershon; Lynn E DeLisi; Alan R Bishop; Hugh M D Gurling; Michele T Pato; Douglas F Levinson; Kenneth S Kendler; Carlos N Pato; Pablo V Gejman Journal: Am J Hum Genet Date: 2014-11-26 Impact factor: 11.025
Authors: Olga Varea; Maria Dolores Martin-de-Saavedra; Katherine J Kopeikina; Britta Schürmann; Hunter J Fleming; Jessica M Fawcett-Patel; Anthony Bach; Seil Jang; Elior Peles; Eunjoon Kim; Peter Penzes Journal: Proc Natl Acad Sci U S A Date: 2015-04-27 Impact factor: 11.205
Authors: Robert E McCullumsmith; John H Hammond; Dan Shan; James H Meador-Woodruff Journal: Neuropsychopharmacology Date: 2013-10-04 Impact factor: 7.853
Authors: Raphael Bernier; Kyle J Steinman; Beau Reilly; Arianne Stevens Wallace; Elliott H Sherr; Nicholas Pojman; Heather C Mefford; Jennifer Gerdts; Rachel Earl; Ellen Hanson; Robin P Goin-Kochel; Leandra Berry; Stephen Kanne; LeeAnne Green Snyder; Sarah Spence; Melissa B Ramocki; David W Evans; John E Spiro; Christa L Martin; David H Ledbetter; Wendy K Chung Journal: Genet Med Date: 2015-06-11 Impact factor: 8.822